Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
Download
.jpg?d=110x100 "User supplied image")
Rabbit polyclonal DDR1 (Tyr513) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human DDR1 around the phosphorylation site of tyrosine 513 (P-A-YP-R-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal VLK Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | VLK antibody was raised against a 15 amino acid synthetic peptide from near the center of human VLK. The immunogen is located within amino acids 320 - 370 of VLK. |
Rabbit Polyclonal IRAK-M Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | IRAK-M antibody was raised against a peptide corresponding to 16 amino acids near the carboxy terminus of human IRAK-M. The immunogen is located within the last 50 amino acids of IRAK-M. |
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal CaMKII (Thr305) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CaMKII around the phosphorylation site of threonine 305 (I-L-TP-T-M). |
| Modifications | Phospho-specific |
Rabbit polyclonal IGF1R (Tyr1346) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IGF1R around the phosphorylation site of tyrosine 1346 (Q-P-YP-A-H). |
| Modifications | Phospho-specific |
Rabbit polyclonal PKC zeta (Thr410) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PKC? around the phosphorylation site of threonine 410 (T-S-TP-F-C). |
| Modifications | Phospho-specific |
Rabbit polyclonal CDK5 (Ab-15) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CDK5 around the phosphorylation site of tyrosine 15 (G-T-YP-G-T) |
Rabbit polyclonal MAP2K7 (Ser271) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human MAP2K7 around the phosphorylation site of serine 271 (V-D-SP-K-A). |
| Modifications | Phospho-specific |
Active filters
Reactivities
- Rat
Applications
- IHC
Families
- Protein Kinase
Filter by
Target Symbol
- MAP2K1 (173)
- ERBB2 (99)
- MAP2K3 (96)
- AKT1 (64)
- RET (47)
- BTK (45)
- MTOR (45)
- NRBP1 (35)
- PIM2 (35)
- TLK2 (35)
- CHEK2 (33)
- PRKCE (32)
- EGFR (31)
- TYRO3 (30)
- MAPK1 (29)
- MAP2K4 (28)
- LIMK1 (27)
- MAPK9 (27)
- ROR2 (26)
- STK39 (25)
- TRIM28 (25)
- BRAF (24)
- PLK1 (23)
- MARK3 (21)
- NEK6 (20)
- TP53RK (20)
- ERBB3 (19)
- RPS6KB1 (18)
- FRK (17)
- MAP2K2 (17)
- PTK2 (17)
- FGFR2 (16)
- MAPK13 (16)
- CDK15 (15)
- CDKL1 (15)
- CSNK1G1 (15)
- MET (15)
- NTRK3 (15)
- PDGFRA (15)
- PRKD2 (15)
- ALK (14)
- MAPK8 (13)
- ACVR2A (11)
- ARAF (11)
- TRIM33 (11)
- CDKL2 (10)
- JAK2 (10)
- MAK (10)
- MAPK4 (10)
- PRKD3 (10)
- STK3 (10)
- STK38L (10)
- AKT3 (9)
- NTRK1 (9)
- NTRK2 (9)
- AKT2 (8)
- CAMK2B (8)
- FGFR3 (8)
- MAP3K8 (8)
- PAK1 (8)
- ERBB4 (7)
- MAPK3 (7)
- PDGFRB (7)
- PIK3R4 (7)
- SGK1 (7)
- STK11 (7)
- BCKDK (6)
- CAMK1D (6)
- DAPK2 (6)
- HIPK1 (6)
- KDR (6)
- MAP2K6 (6)
- MAPK12 (6)
- MAPK14 (6)
- MAPK6 (6)
- MOK (6)
- PAK4 (6)
- SRC (6)
- TWF1 (6)
- CHUK (5)
- CSNK1E (5)
- CSNK1G2 (5)
- GSK3A (5)
- MARK4 (5)
- OXSR1 (5)
- PKMYT1 (5)
- PRKCA (5)
- PRKG1 (5)
- PTK2B (5)
- RAF1 (5)
- ROR1 (5)
- RPS6KA1 (5)
- TGFBR2 (5)
- TRIB1 (5)
- TRPM7 (5)
- UHMK1 (5)
- CDK1 (4)
- CDK5 (4)
- EIF2AK3 (4)
- GSK3B (4)
Antibody Hosts
Isotypes
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (755)
- MAPK signaling pathway (732)
- ErbB signaling pathway (707)
- Focal adhesion (611)
- Fc epsilon RI signaling pathway (606)
- Prostate cancer (582)
- Toll-like receptor signaling pathway (530)
- Pancreatic cancer (528)
- GnRH signaling pathway (506)
- Non-small cell lung cancer (492)
- Endometrial cancer (488)
- Insulin signaling pathway (479)
- Neurotrophin signaling pathway (479)
- Glioma (471)
- Colorectal cancer (460)
- Acute myeloid leukemia (454)
- Progesterone-mediated oocyte maturation (448)
- Melanoma (424)
- T cell receptor signaling pathway (423)
- Regulation of actin cytoskeleton (422)
- Bladder cancer (412)
- Chemokine signaling pathway (409)
- Fc gamma R-mediated phagocytosis (402)
- Renal cell carcinoma (385)
- VEGF signaling pathway (381)
- B cell receptor signaling pathway (375)
- Chronic myeloid leukemia (371)
- Vascular smooth muscle contraction (335)
- Gap junction (318)
- Thyroid cancer (306)
- Long-term potentiation (299)
- Natural killer cell mediated cytotoxicity (294)
- Long-term depression (285)
- Oocyte meiosis (276)
- Melanogenesis (260)
- Dorso-ventral axis formation (240)
- Prion diseases (233)
- mTOR signaling pathway (228)
- Adherens junction (217)
- Calcium signaling pathway (213)
- Endocytosis (211)
- Adipocytokine signaling pathway (205)
- Epithelial cell signaling in Helicobacter pylori infection (167)
- Type II diabetes mellitus (163)
- Axon guidance (144)
- Tight junction (143)
- Amyotrophic lateral sclerosis (ALS) (131)
- NOD-like receptor signaling pathway (115)
- Small cell lung cancer (110)
- Apoptosis (108)
- Cytokine-cytokine receptor interaction (105)
- Jak-STAT signaling pathway (96)
- Wnt signaling pathway (94)
- TGF-beta signaling pathway (91)
- RIG-I-like receptor signaling pathway (84)
- Cell cycle (76)
- Leukocyte transendothelial migration (64)
- Alzheimer's disease (48)
- Primary immunodeficiency (47)
- p53 signaling pathway (42)
- Hedgehog signaling pathway (40)
- Olfactory transduction (25)
- Regulation of autophagy (16)
- Vibrio cholerae infection (14)
- Pathogenic Escherichia coli infection (13)
- Cytosolic DNA-sensing pathway (11)
- Hypertrophic cardiomyopathy (HCM) (8)
- Phosphatidylinositol signaling system (8)
- PPAR signaling pathway (7)
- Circadian rhythm - mammal (6)
- Dilated cardiomyopathy (6)
- Taste transduction (6)
- Basal cell carcinoma (4)
- Purine metabolism (3)
- Viral myocarditis (3)
- Hematopoietic cell lineage (2)
- Parkinson's disease (2)
- Nucleotide excision repair (1)
- Ubiquitin mediated proteolysis (1)